Brydges, Christopher, Che, Xiaoyu, Lipkin, Walter Ian et al. · Metabolites · 2023 · DOI
This study compared blood chemistry samples from three different groups of ME/CFS patients and healthy people to find differences in metabolites—small molecules in the blood. Instead of using the traditional statistical method, researchers used a newer approach called Bayesian statistics that allows them to combine results from multiple studies to find patterns that traditional methods missed. They discovered several important differences in blood metabolites between ME/CFS patients and healthy controls, including abnormal fat molecules and reduced levels of prostaglandin F2alpha.
This study provides a statistical framework that may help researchers identify subtle but biologically important metabolic changes in ME/CFS that previous methods failed to detect. The consistent finding of reduced prostaglandin F2alpha across all three independent datasets suggests a potentially meaningful biological marker. Better analysis methods could accelerate discovery of metabolic abnormalities underlying ME/CFS pathology.
This study does not prove that the identified metabolite changes cause ME/CFS symptoms or establish mechanistic relationships. It does not validate whether these metabolite differences are useful as diagnostic biomarkers in clinical practice. The methodology paper demonstrates a statistical approach but does not prove these findings will replicate in future, independently-collected cohorts.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.